[go: up one dir, main page]

FR2940909B1 - Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil - Google Patents

Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil

Info

Publication number
FR2940909B1
FR2940909B1 FR0900135A FR0900135A FR2940909B1 FR 2940909 B1 FR2940909 B1 FR 2940909B1 FR 0900135 A FR0900135 A FR 0900135A FR 0900135 A FR0900135 A FR 0900135A FR 2940909 B1 FR2940909 B1 FR 2940909B1
Authority
FR
France
Prior art keywords
malathion
pharmaceutical composition
cyclic silicone
volatile cyclic
volatile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0900135A
Other languages
English (en)
Other versions
FR2940909A1 (fr
Inventor
Michel Jeanjean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Priority to FR0900135A priority Critical patent/FR2940909B1/fr
Priority to EP10706290A priority patent/EP2385822A1/fr
Priority to US13/138,130 priority patent/US20110269718A1/en
Priority to JP2011544910A priority patent/JP2012515153A/ja
Priority to PCT/FR2010/050029 priority patent/WO2010079310A1/fr
Publication of FR2940909A1 publication Critical patent/FR2940909A1/fr
Application granted granted Critical
Publication of FR2940909B1 publication Critical patent/FR2940909B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FR0900135A 2009-01-12 2009-01-12 Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil Expired - Fee Related FR2940909B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0900135A FR2940909B1 (fr) 2009-01-12 2009-01-12 Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil
EP10706290A EP2385822A1 (fr) 2009-01-12 2010-01-11 Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil
US13/138,130 US20110269718A1 (en) 2009-01-12 2010-01-11 Pharmaceutical composition containing malathion and volatile cyclic silicone
JP2011544910A JP2012515153A (ja) 2009-01-12 2010-01-11 マラチオンおよび揮発性環状シリコーンを含む医薬組成物
PCT/FR2010/050029 WO2010079310A1 (fr) 2009-01-12 2010-01-11 Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0900135A FR2940909B1 (fr) 2009-01-12 2009-01-12 Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil

Publications (2)

Publication Number Publication Date
FR2940909A1 FR2940909A1 (fr) 2010-07-16
FR2940909B1 true FR2940909B1 (fr) 2011-02-11

Family

ID=40627516

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0900135A Expired - Fee Related FR2940909B1 (fr) 2009-01-12 2009-01-12 Composition pharmaceutique comprenant du malathion et un silicone cyclique volatil

Country Status (5)

Country Link
US (1) US20110269718A1 (fr)
EP (1) EP2385822A1 (fr)
JP (1) JP2012515153A (fr)
FR (1) FR2940909B1 (fr)
WO (1) WO2010079310A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012150891A1 (fr) * 2011-05-02 2012-11-08 Lipidor Ab Composition destinée à l'administration d'un agent pharmacologiquement ou cosmétiquement actif sur une surface d'un organisme vivant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172737B1 (da) * 1996-08-20 1999-06-21 Cheminova Agro As Malathion olie-i-vand emulsionsformuleringer, samt anvendelse af peroxid i sådanne formuleringer
US6663876B2 (en) * 2002-04-29 2003-12-16 Piedmont Pharmaceuticals, Llc Methods and compositions for treating ectoparasite infestation
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060121073A1 (en) * 2004-07-12 2006-06-08 Sandhya Goyal Topical gel formulation comprising insecticide and its preparation thereof

Also Published As

Publication number Publication date
WO2010079310A1 (fr) 2010-07-15
FR2940909A1 (fr) 2010-07-16
EP2385822A1 (fr) 2011-11-16
US20110269718A1 (en) 2011-11-03
JP2012515153A (ja) 2012-07-05

Similar Documents

Publication Publication Date Title
IL219947A (en) Cyclic peptides and pharmaceutical preparations containing them
HK1249868A1 (zh) 揮發性物質的分配器及其分配篩網
FR2958157B1 (fr) Composition cosmetique et pharmaceutique comprenant du n-acetyl-glucosamine-6-phosphate
FR2948568B1 (fr) Formulation pharmaceutique
DK3643347T3 (da) Lægemiddelleveringsanordning med et forbedret stempel
FR18C1032I2 (fr) Anticorps anti-fgf23 et composition pharmaceutique le comprenant
EP2475649A4 (fr) Dérivé d'indénone et composition pharmaceutique le comprenant
DK3278665T3 (da) Stabil farmaceutisk sammensætning og fremgangsmåder til anvendelse deraf
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
BR112012002804A2 (pt) dispositivo com sensor e uma ou mais cânulas
ME02575B (fr) Composition pharmaceutique
EP2393541A4 (fr) Support ventilatoire et dispositif de réanimation et procédé associé
EP2565235A4 (fr) Composition de type gel de silicone photodurcissable et son application
EP2566468A4 (fr) Revêtement de délivrance de médicaments et dispositifs
EP2408912A4 (fr) Peptides foxm1 et vaccins contenant ceux-ci
BR112013015356A2 (pt) formulações de aerossol com gomas de silicone e lipídeos sepeciais
EP2908868A4 (fr) Récipient désodorisant et désinfectant
DK2353632T3 (da) Medicinsk anordning til lokal lægemiddelafgivelse
BRPI0822603A2 (pt) Formulação farmacêutica contendo palmitoil etanolamina e estearoil etanolamina.
BR112013014833A2 (pt) novas formulações farmacêticas compreendendo aine e ciclodextrina
EP2277861A4 (fr) Dérivé d ester d acide (amine cyclique)-1-carboxylique et composition pharmaceutique le contenant
HRP20180793T1 (hr) Farmaceutski pripravak i oblik doziranja koji sadrži dronedaron, te postupak njegove priprave
GB201010592D0 (en) Volatile liquid emanation device
EP2322505A4 (fr) Dérivé 1-adamantylazétidine-2-one et préparation pharmaceutique comprenant ce dérivé
IL217614A (en) Indolysin and 5-Azo-Indolysin Ring Carboxyamides, Their Converted History and Pharmaceuticals Containing Them

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130930